{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:33:48Z","timestamp":1789659228920,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1124\/mol.112.080788","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T00:18:01Z","timestamp":1351037881000},"page":"245-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Requirement of Apoptotic Protease-Activating Factor-1 for Bortezomib-Induced Apoptosis but Not for Fas-Mediated Apoptosis in Human Leukemic Cells"],"prefix":"10.1016","volume":"83","author":[{"given":"Astrid","family":"Ottosson-Wadlund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Ceder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Preta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Pokrovskaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland C.","family":"Grafstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"S\u00f6derh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Grand\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hedenfalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Fadeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.112.080788_bib1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/sj.leu.2402201","article-title":"Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an approximately 700 kDa Apaf-1 containing apoptosome complex","volume":"15","author":"Almond","year":"2001","journal-title":"Leukemia"},{"key":"10.1124\/mol.112.080788_bib2","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3324\/haematol.2010.022368","article-title":"Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells","volume":"95","author":"Baou","year":"2010","journal-title":"Haematologica"},{"key":"10.1124\/mol.112.080788_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-005-9016-3","article-title":"Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8","volume":"287","author":"Calvaruso","year":"2006","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/mol.112.080788_bib4","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood-2007-08-105601","article-title":"Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma","volume":"111","author":"Chauhan","year":"2008","journal-title":"Blood"},{"key":"10.1124\/mol.112.080788_bib5","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1158\/0008-5472.CAN-09-4428","article-title":"Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080788_bib6","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1158\/1078-0432.CCR-03-0508","article-title":"Phase I study of bortezomib in refractory or relapsed acute leukemias","volume":"10","author":"Cortes","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.112.080788_bib7","first-page":"3535","article-title":"Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition","volume":"61","author":"Cusack","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080788_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","article-title":"Cell death: critical control points","volume":"116","author":"Danial","year":"2004","journal-title":"Cell"},{"key":"10.1124\/mol.112.080788_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.cdd.4402265","article-title":"Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance","volume":"15","author":"Fadeel","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1124\/mol.112.080788_bib10","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1073\/pnas.1121341109","article-title":"Bortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cells","volume":"109","author":"Fang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.080788_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/BJ20061576","article-title":"Requirement of Apaf-1 for mitochondrial events and the cleavage or activation of all procaspases during genotoxic stress-induced apoptosis","volume":"405","author":"Franklin","year":"2007","journal-title":"Biochem J"},{"key":"10.1124\/mol.112.080788_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.onc.1206147","article-title":"Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia","volume":"22","author":"Fu","year":"2003","journal-title":"Oncogene"},{"key":"10.1124\/mol.112.080788_bib13","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1158\/0008-5472.CAN-06-4322","article-title":"Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma","volume":"67","author":"Gomez-Bougie","year":"2007","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080788_bib14","doi-asserted-by":"crossref","first-page":"16220","DOI":"10.1073\/pnas.252462599","article-title":"Preferential induction of apoptosis for primary human leukemic stem cells","volume":"99","author":"Guzman","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.080788_bib15","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"Hideshima","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080788_bib16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1182\/blood.V98.2.414","article-title":"Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells","volume":"98","author":"Jia","year":"2001","journal-title":"Blood"},{"key":"10.1124\/mol.112.080788_bib17","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.onc.1206322","article-title":"Role of Smac in human leukaemic cell apoptosis and proliferation","volume":"22","author":"Jia","year":"2003","journal-title":"Oncogene"},{"key":"10.1124\/mol.112.080788_bib18","doi-asserted-by":"crossref","first-page":"27827","DOI":"10.1074\/jbc.M109.027912","article-title":"N(\u03b1)-tosyl-L-phenylalanine chloromethyl ketone induces caspase-dependent apoptosis in transformed human B cell lines with transcriptional down-regulation of anti-apoptotic HS1-associated protein X-1","volume":"284","author":"Jitkaew","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.080788_bib19","first-page":"797","article-title":"FADD is required for multiple signaling events downstream of the receptor Fas","volume":"10","author":"Juo","year":"1999","journal-title":"Cell Growth Differ"},{"key":"10.1124\/mol.112.080788_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jcp.20638","article-title":"The course of etoposide-induced apoptosis in Jurkat cells lacking p53 and Bax","volume":"208","author":"Karpinich","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1124\/mol.112.080788_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ijc.21311","article-title":"Betulinic acid, a natural cytotoxic agent, fails to trigger apoptosis in human Burkitt\u2019s lymphoma-derived B-cell lines","volume":"118","author":"Karpova","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1124\/mol.112.080788_bib22","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1073\/pnas.87.18.7071","article-title":"Abnormally high expression of proteasomes in human leukemic cells","volume":"87","author":"Kumatori","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.112.080788_bib23","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/leu.2010.321","article-title":"HAX-1 expression in human B lymphoma","volume":"25","author":"Kwiecinska","year":"2011","journal-title":"Leukemia"},{"key":"10.1124\/mol.112.080788_bib24","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3324\/haematol.10543","article-title":"Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members","volume":"92","author":"Laane","year":"2007","journal-title":"Haematologica"},{"key":"10.1124\/mol.112.080788_bib25","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1158\/0008-5472.CAN-06-4274","article-title":"The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells","volume":"67","author":"Liu","year":"2007","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080788_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nbt0410-322","article-title":"A global map of human gene expression","volume":"28","author":"Lukk","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1124\/mol.112.080788_bib27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1046\/j.1365-2141.1999.01388.x","article-title":"Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin","volume":"105","author":"Masdehors","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1124\/mol.112.080788_bib28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.leukres.2009.09.020","article-title":"Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status","volume":"34","author":"Matondo","year":"2010","journal-title":"Leuk Res"},{"key":"10.1124\/mol.112.080788_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/pbc.22456","article-title":"Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortium","volume":"55","author":"Messinger","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1124\/mol.112.080788_bib30","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1182\/blood-2002-06-1768","article-title":"The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications","volume":"101","author":"Mitsiades","year":"2003","journal-title":"Blood"},{"key":"10.1124\/mol.112.080788_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1535-7163.MCT-04-0260","article-title":"The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim","volume":"4","author":"Nikrad","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/mol.112.080788_bib32","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1200\/JCO.2002.01.133","article-title":"Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies","volume":"20","author":"Orlowski","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1124\/mol.112.080788_bib33","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1158\/1078-0432.CCR-07-2218","article-title":"Proteasome inhibitors in cancer therapy: lessons from the first decade","volume":"14","author":"Orlowski","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.112.080788_bib34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2005-05-2091","article-title":"The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status","volume":"107","author":"P\u00e9rez-Gal\u00e1n","year":"2006","journal-title":"Blood"},{"key":"10.1124\/mol.112.080788_bib35","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1158\/0008-5472.CAN-05-0676","article-title":"Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells","volume":"65","author":"Qin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.080788_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/1471-2407-10-377","article-title":"Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy","volume":"10","author":"Ragusa","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1124\/mol.112.080788_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0360-3016(01)01446-8","article-title":"Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB","volume":"50","author":"Russo","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1124\/mol.112.080788_bib38","doi-asserted-by":"crossref","first-page":"R65.1","DOI":"10.1186\/gb-2005-6-8-r65","article-title":"The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles","volume":"6","author":"Sandberg","year":"2005","journal-title":"Genome Biol"},{"key":"10.1124\/mol.112.080788_bib39","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/emboj\/17.6.1675","article-title":"Two CD95 (APO-1\/Fas) signaling pathways","volume":"17","author":"Scaffidi","year":"1998","journal-title":"EMBO J"},{"key":"10.1124\/mol.112.080788_bib40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.2910190505","article-title":"Characterization of EBV-genome negative \u201cnull\u201d and \u201cT\u201d cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma","volume":"19","author":"Schneider","year":"1977","journal-title":"Int J Cancer"},{"key":"10.1124\/mol.112.080788_bib41","doi-asserted-by":"crossref","first-page":"33447","DOI":"10.1074\/jbc.M109.032359","article-title":"Caspase-9 activation by the apoptosome is not required for fas-mediated apoptosis in type II Jurkat cells","volume":"284","author":"Shawgo","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.080788_bib42","doi-asserted-by":"crossref","first-page":"40525","DOI":"10.1074\/jbc.M110.167635","article-title":"Activation of caspase-9, but not caspase-2 or caspase-8, is essential for heat-induced apoptosis in Jurkat cells","volume":"285","author":"Shelton","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.080788_bib43","doi-asserted-by":"crossref","first-page":"17682","DOI":"10.1074\/jbc.M110.189092","article-title":"Noxa\/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells","volume":"286","author":"Smith","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.080788_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35051606","article-title":"Inactivation of the apoptosis effector Apaf-1 in malignant melanoma","volume":"409","author":"Soengas","year":"2001","journal-title":"Nature"},{"key":"10.1124\/mol.112.080788_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2141.2001.02683.x","article-title":"The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI","volume":"113","author":"Soligo","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1124\/mol.112.080788_bib46","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/ijc.21535","article-title":"Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation","volume":"118","author":"Sturm","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1124\/mol.112.080788_bib47","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2004-10-4075","article-title":"Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance","volume":"105","author":"Sun","year":"2005","journal-title":"Blood"},{"key":"10.1124\/mol.112.080788_bib48","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/sj.leu.2404660","article-title":"Smac-mediated sensitization of human B-lymphoma cells to staurosporine- and lactacystin-triggered apoptosis is apoptosome-dependent","volume":"21","author":"Sun","year":"2007","journal-title":"Leukemia"},{"key":"10.1124\/mol.112.080788_bib49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0014-5793(03)00508-8","article-title":"Phosphatidylserine exposure in Fas type I cells is mitochondria-dependent","volume":"545","author":"Uthaisang","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.112.080788_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2141.2006.06170.x","article-title":"Proteasome inhibition as novel treatment strategy in leukaemia","volume":"134","author":"Vink","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1124\/mol.112.080788_bib51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.leukres.2007.05.024","article-title":"Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies","volume":"32","author":"Zhao","year":"2008","journal-title":"Leuk Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2403623X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X2403623X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.112.080788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:17:23Z","timestamp":1740039443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X2403623X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0026895X2403623X"],"URL":"https:\/\/doi.org\/10.1124\/mol.112.080788","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Requirement of Apoptotic Protease-Activating Factor-1 for Bortezomib-Induced Apoptosis but Not for Fas-Mediated Apoptosis in Human Leukemic Cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.112.080788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}